Comprehensive Index of National Vaccine Injury Compensation Program Cases ← all cases Home Firms Attorneys Stats Special Masters About Us

Larkin Hoffman, et al., Ltd.

Law Firm · Petitioner Practice VICP Petitioner Practice Last verified
Cases filed
9
Comp rate
78%
Total awarded
$2.5M
Tenure
2016–2019
Heads up: The case docket, statistics, and overview below are compiled from AI-extracted data. Specific figures (case counts, awards, outcomes) may contain errors. Verify with the firm directly or with source court records before relying on them.
Larkin Hoffman, et al., Ltd. is a U.S. law firm whose name appears on 9 petitions in the National Vaccine Injury Compensation Program. The firm's filings on file span 2016-2019, with a compensation rate of 78%. Cases on file have produced $2.5M in total awards. The attorneys appearing on this firm's docket include Kate Gerayne Westad.
AI-generated overview · may contain errors. Verify details with the firm directly before relying on them.
Attorneys at this firm (by case volume)
Kate Gerayne Westad9
Most-handled condition categories
Guillain-Barré Syndrome (GBS)4Other / multiple3Transverse myelitis2

Compensation rate by condition vs program baseline

For each condition this firm has handled at least 3 cases on, comparing the firm's comp rate against the program-wide comp rate for the same condition. Reveals where this firm out- or under-performs the baseline.

Guillain-Barré Syndrome (GBS) +18pt vs program
4 cases at this firm · 4 compensated
This firm
100%
Program
82%
Other / multiple +32pt vs program
3 cases at this firm · 2 compensated
This firm
67%
Program
35%

Frequently asked questions about Larkin Hoffman, et al., Ltd.

Answers built from this firm's public case docket.

How do I find a good VICP lawyer?
Most petitioners hire counsel because the program's evidentiary burden, expert-witness requirements, and procedural rules are complex. Reasonable attorney fees in VICP cases are paid by the program — not by the petitioner — under 42 U.S.C. § 300aa-15(e)(1), so engaging counsel does not reduce a successful petitioner's recovery. You can submit a free inquiry → to have your case forwarded to attorneys with VICP experience, or research Larkin Hoffman, et al., Ltd.'s case history below.
How many VICP cases has Larkin Hoffman, et al., Ltd. filed?
Larkin Hoffman, et al., Ltd. has filed 9 petitions in the U.S. Vaccine Injury Compensation Program with publicly-available decisions, between 2016 and 2019.
What is Larkin Hoffman, et al., Ltd.'s compensation rate?
Larkin Hoffman, et al., Ltd.'s overall compensation rate across 9 VICP cases is 78% (7 compensated).
How much has Larkin Hoffman, et al., Ltd. won in VICP cases?
Cases filed by Larkin Hoffman, et al., Ltd. have resulted in $2.5M in total compensation awards from the U.S. Vaccine Injury Compensation Program (visible-in-public-decisions only).
What kinds of vaccine injury cases does Larkin Hoffman, et al., Ltd. handle?
Based on the cases on file, Larkin Hoffman, et al., Ltd.'s practice includes Guillain-Barré Syndrome (GBS), Other / multiple, Transverse myelitis, among other vaccine-related conditions.
FiledFinal judgementPetitionerAttorneyFirm Age at VaccinationVaccineCondition OutcomeSpecial MasterAward
2017-11-212019-05-15MARK PFEIFER, as Administrator of the Estate of RONALD VINCENT PFEIFER, deceaseddeathKate Gerayne WestadLarkin, Hoffman, et al., Ltd.–influenzaGuillain-Barré Syndrome (GBS) and respiratory failurecompensatedNora Beth Dorsey$465,000
2013-08-202019-03-01R.P.Kate Gerayne WestadLarkin Hoffman, et al., Ltd.6moinfluenzatransverse myelitisdeniedBrian H. Corcoran–
2016-09-292018-09-06James I. MoranKate Gerayne WestadLarkin Hoffman, et al., Ltd.–influenzaChronic Inflammatory Demyelinating Polyneuropathy (CIDP)compensatedThomas L. Gowen$175,000
2014-01-022018-05-01L.R.Kate G. WestadLarkin Hoffman, et al, Ltd.–DTaP, IPV/OPV, PCV-13, Hep B, acute-onset Transverse Myelitis (“TM”)compensatedMindy Michaels Roth$1,181,999
2017-09-262018-02-05Curtis BakkenKate G. WestadLarkin Hoffman, et al., Ltd.–influenzaGuillain-Barré Syndrome (GBS)compensatedNora Beth Dorsey$138,000
2016-10-062017-10-10William R. ChoiniereKate Gerayne WestadLarkin Hoffman, et al., Ltd.–influenzachronic demyelinating polyneuropathy ("CIDP")compensatedChristian J. Moran$148,000
2016-10-062017-05-10Noreen FontanaKate G. WestadLarkin Hoffman, et al., Ltd.–influenzaChronic Inflammatory Demyelinating Polyneuropathy (CIDP)compensatedThomas L. Gowen$135,000
2013-02-052017-04-20Richard T. DahlKate G. WestadLarkin Hoffman, et al. Ltd.–influenzaGuillain-Barré SyndromecompensatedChristian J. Moran$273,000
2012-09-252016-07-27A.R.Kate G. WestadLarkin Hoffman, et al., Ltd.3.2yHepatitis Anephrotic syndromedeniedThomas L. Gowen–